D.E. Shaw & Co
JAZZ icon

D.E. Shaw & Co’s Jazz Pharmaceuticals JAZZ Stock Holding History

D.E. Shaw & Co’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-20,400
Closed -$3.04M – 4094
2019
Q4 		$3.04M Buy
+20,400
New +$2.78M ﹤0.01% 2139
2017
Q4 		– Sell
-5,700
Closed -$834K – 3650
2017
Q3 		$834K Hold
5,700
– – ﹤0.01% 2603
2017
Q2 		$886K Buy
+5,700
New +$872K ﹤0.01% 2489
2014
Q3 		– Sell
-2,500
Closed -$368K – 4236
2014
Q2 		$368K Buy
+2,500
New +$347K ﹤0.01% 3728

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

D.E. Shaw & Co's JAZZ Position: Q1 2026 in Review

D.E. Shaw & Co increased its Jazz Pharmaceuticals (JAZZ) stake by 50% in Q1 2026, buying an estimated $17.3M and bringing the position to 298,090 shares worth $56.4M. The position accounts for 0.03% of the portfolio, ranked #607.

D.E. Shaw & Co first reported a position in JAZZ in Q2 2013 and has held it in 40 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • D.E. Shaw & Co held 298,090 shares of Jazz Pharmaceuticals worth $56.4M as of Q1 2026.
  • D.E. Shaw & Co bought 98,788 Jazz Pharmaceuticals shares in Q1 2026, an estimated $17.3M.
  • Jazz Pharmaceuticals made up 0.03% of D.E. Shaw & Co's portfolio in Q1 2026, its #607 holding.
  • D.E. Shaw & Co first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 40 quarters since.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.